CareCloud (NASDAQ: CCLD) executives emphasized accelerating profitability, stronger cash generation, and a broadened product footprint during the company's fourth-quarter and full-year 2025 earnings call, highlighting strategic acquisitions and what management described as early traction for its newly launched AI offerings. 2025 results: revenue growth, first full year of positive GAAP EPS since IPO CEO Stephen Snyder
Zacks Medical Info Systems industry stocks like Inspire Medical Systems, Clover Health Investments and CareCloud are expected to gain from the GenAI wave.